This study was completed to evaluate the possible from the CPPs with tumor-targeting Attributes to deliver a cytotoxic payload to HCC cells. We explored utilizing a CXCR4-targeting peptide, T22, fused with cytotoxic peptide PE24, being a novel therapeutic strategy for CXCR4+ HCC cells. T22 was decided on given that the https://stevee073lqt4.evawiki.com/user